Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”

James Cheng Chung Wei; Ching Nung Wu; Wei Chun Cheng

doi:10.1053/j.gastro.2024.09.039

Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”

James Cheng Chung Wei
, Ching Nung Wu
, Wei Chun Cheng

School of Traditional Chinese Medicine

Research output: Contribution to journal › Journal Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	424
Number of pages	1
Journal	Gastroenterology
Volume	168
Issue number	2
DOIs	https://doi.org/10.1053/j.gastro.2024.09.039
State	Published - 02 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1053/j.gastro.2024.09.039

Cite this

@article{e3b3ce4819694380bb8e51698a2fa534,

title = "Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”",

author = "Wei, \{James Cheng Chung\} and Wu, \{Ching Nung\} and Cheng, \{Wei Chun\}",

year = "2025",

month = feb,

doi = "10.1053/j.gastro.2024.09.039",

language = "英语",

volume = "168",

pages = "424",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”

AU - Wei, James Cheng Chung

AU - Wu, Ching Nung

AU - Cheng, Wei Chun

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85214342664

U2 - 10.1053/j.gastro.2024.09.039

DO - 10.1053/j.gastro.2024.09.039

M3 - 文章

C2 - 39426486

AN - SCOPUS:85214342664

SN - 0016-5085

VL - 168

SP - 424

JO - Gastroenterology

JF - Gastroenterology

IS - 2

ER -

Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”

UN SDGs

Access to Document

Other files and links

Cite this